Obstructive Sleep Apnea: A Growing Economic and Health Burden

Obstructive sleep apnea (OSA) is a common yet often undiagnosed condition affecting an estimated 1 billion people worldwide, including 8 million in the UK. Characterized by repeated interruptions in breathing during sleep, OSA extends beyond causing daytime fatigue and significantly impacts both individual health and global economies.

The Economic Impact of Untreated Sleep Apnea

Recent research highlights the substantial economic consequences of untreated OSA. A study led by researchers at University College London, surveying over 4,000 adults in the UK and US, estimated that OSA costs the US economy $180 billion (£133 billion) and the UK economy £4.2 billion annually [1]. These costs stem primarily from lost workdays and reduced productivity while at work.

Researchers acknowledge that this figure is likely an underestimate, as it doesn’t account for increased medical expenses or the costs associated with road traffic and workplace accidents [1]. The study, published in the journal Thorax, emphasizes the necessitate for proactive screening and public health initiatives.

Understanding Obstructive Sleep Apnea

OSA occurs when the muscles in the throat relax during sleep, causing a narrowing or blockage of the airway [1]. This leads to pauses in breathing, often accompanied by loud snoring and gasping for air. These interruptions can happen multiple times per hour, even as frequently as once every one to two minutes in severe cases [1].

There are two main types of breathing interruption associated with OSA:

• Apnea: A complete blockage of the airway for 10 seconds or more.
• Hypopnea: A partial blockage of the airway causing a reduction in airflow of more than 50% for 10 seconds or more [1].

OSA is sometimes referred to as obstructive sleep apnea-hypopnea syndrome (OSAHS) [1].

Symptoms of OSA

Common signs and symptoms of OSA include [2]:

• Excessive daytime sleepiness
• Breathing pauses during sleep (often noticed by a partner)
• Loud snoring
• Noisy or labored breathing
• Waking up gasping or snorting
• Night sweats
• Frequent nighttime urination

Individuals with OSA often experience fragmented sleep and may not be aware of their breathing interruptions [1].

Diagnosis and Treatment

If a healthcare professional suspects OSA, they may refer a patient to a sleep clinic for testing [2]. Tests typically involve monitoring breathing and heartbeat during sleep, often conducted at home, though overnight stays in a clinic may sometimes be necessary.

The severity of OSA is often measured using an AHI (Apnea-Hypopnea Index) score [2]:

• AHI of 5 to 14 = Mild
• AHI of 15 to 30 = Moderate
• AHI over 30 = Severe

Continuous positive airway pressure (CPAP) therapy is generally considered the most effective treatment for OSA, involving the use of a machine to deliver constant air pressure through a mask during sleep . However, adherence to CPAP therapy can be challenging, with nearly two-thirds of patients discontinuing its use.

Alternative treatments include weight loss, mouth guards, and hypoglossal nerve stimulation implants, though suitability varies among patients .

Addressing Barriers to Screening and Treatment

Concerns exist regarding potential job insecurity for workers diagnosed with OSA, particularly in professions like driving. Unite, a trade union, supports screening but emphasizes the need for employer education and worker protection to ensure individuals perceive safe reporting symptoms and seeking treatment [1].

The Path Forward

The growing recognition of OSA’s economic and health burdens underscores the importance of widespread screening, early diagnosis, and effective treatment. Investing in low-cost technologies and public health campaigns could significantly reduce the impact of this prevalent condition and improve the well-being of millions.